Analysts Are Bullish on These Healthcare Stocks: CGNT, LGND

By Jason Carr

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cogentix Medical Inc (NASDAQ: CGNT) and Ligand Pharma (NASDAQ: LGND) with bullish sentiments.

Cogentix Medical Inc (NASDAQ: CGNT)

In a report issued on May 19, Chris Lewis from Roth Capital reiterated a Buy rating on Cogentix Medical Inc (NASDAQ: CGNT), with a price target of $2.30. The company’s shares opened today at $1.69.

According to TipRanks.com, Lewis is a 4-star analyst with an average return of 4.9% and a 48.4% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Trinity Biotech Plc, Lemaitre Vascular, and Natus Medical Inc.

Cogentix Medical Inc has an analyst consensus of Moderate Buy, with a price target consensus of $2.30.

Ligand Pharma (NASDAQ: LGND)

In a report released today, Scott Henry from Roth Capital reiterated a Buy rating on Ligand Pharma (NASDAQ: LGND), with a price target of $120. The company’s shares opened today at $113.84.

Henry observed:

“We recently met with the management of Ligand Pharmaceuticals. Our key takeaway is that the current business trends appear strong for the coming years. Further, the next growth engine appears OmniAb, which should drive growth well into the future.”

According to TipRanks.com, Henry is ranked 0 out of 5 stars with an average return of -2.7% and a 43.3% success rate. Henry covers the Healthcare sector, focusing on stocks such as Acerus Pharmaceuticals Corporation, Avadel Pharmaceuticals plc, and Novelion Therapeutics Inc.

Ligand Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $120.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.